Grannum R Sant
Overview
Explore the profile of Grannum R Sant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konety B, Shore N, Sant G
Ther Adv Urol
. 2024 Sep;
16:17562872241280005.
PMID: 39315392
Non-muscle-invasive bladder cancer (NMIBC), which is restricted to the mucosa (stage Ta, carcinoma in situ (CIS)) or submucosa (stage T1), comprises 75% of bladder cancer diagnoses. Intravesical bacillus Calmette-Guérin (BCG)...
2.
Narayan V, Meeks J, Jakobsen J, Shore N, Sant G, Konety B
Front Oncol
. 2024 Apr;
14:1359725.
PMID: 38559556
Effective bladder-preserving therapeutic options are needed for patients with bacillus Calmette-Guérin unresponsive non-muscle-invasive bladder cancer. Nadofaragene firadenovec-vncg (Adstiladrin) was approved by the US Food and Drug Administration as the first...
3.
4.
Tutrone R, Lowentritt B, Neuman B, Donovan M, Hallmark E, Cole T, et al.
Prostate Cancer Prostatic Dis
. 2023 Jun;
27(1):161.
PMID: 37337052
No abstract available.
5.
Tutrone R, Lowentritt B, Neuman B, Donovan M, Hallmark E, Cole T, et al.
Prostate Cancer Prostatic Dis
. 2023 May;
26(3):596-601.
PMID: 37193776
Background: Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of the ExoDx...
6.
Moul J, Sant G
Can J Urol
. 2022 Aug;
29(4):11224-11230.
PMID: 35969726
Prostate-specific antigen (PSA) screening remains the mainstay for early detection of prostate cancer. Although PSA is a nonspecific prostate cancer biomarker, its specificity for high grade prostate cancer can be...
7.
Varsanik J, Manak M, Whitfield M, Hogan B, Su W, Jiang C, et al.
Rev Urol
. 2021 Apr;
22(4):159-167.
PMID: 33927573
To the usefulness and applications of machine vision (MV) and machine learning (ML) techniques that have been used to develop a single cell-based phenotypic (live and fixed biomarkers) platform that...
8.
Towner R, Greenwood-Van Meerveld B, Mohammadi E, Saunders D, Smith N, Sant G, et al.
Pharmacol Res Perspect
. 2021 Feb;
9(1):e00709.
PMID: 33540486
Few therapeutic options exist for treatment of IC/BPS. A novel high MW GAG biopolymer ("SuperGAG") was synthesized by controlled oligomerization of CS, purified by TFF and characterized by SEC-MALLS and...
9.
10.
Manak M, Varsanik J, Hogan B, Whitfield M, Su W, Joshi N, et al.
Nat Biomed Eng
. 2019 Mar;
2(10):761-772.
PMID: 30854249
The risk stratification of prostate cancer and breast cancer tumours from patients relies on histopathology, selective genomic testing, or on other methods employing fixed formalin tissue samples. However, static biomarker...